Media contacts
Christine DeLong
ADLM
Director, Editorial and Media Relations
(p) 202.835.8722
[email protected]
Bill Malone
ADLM
Senior Director, Strategic Communications
(p) 202.835.8756
[email protected]
WASHINGTON – Join the American Association for Clinical Chemistry (AACC) and leading experts in laboratory medicine and diagnostic testing for a discussion of how laboratory medicine is driving the future of personalized medicine and the policies to support these new technologies.
Speakers will address:
Advances in laboratory testing science and technology are providing new opportunities to personalize medical decisions, resulting in better patient outcomes. Better understanding the underlying biology and unique genetics of how specific patients will respond to treatments will mean that health care professionals can avoid the “trial and error” of prescribing treatments which may only work in a small fraction of patients (for example, 43 percent of patients don’t respond to commonly prescribed drugs for diabetes).
When: Lunch Briefing: 11:30 am – 12:30 pm, Wednesday, October 14, 2015
Where: Room 2168, Rayburn House Office Building
Who:
RSVP: Email Christine DeLong at [email protected].
Dedicated to achieving better health through laboratory medicine, AACC brings together more than 50,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science. Since 1948, AACC has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. For more information, visit www.myadlm.org.